Warning: Undefined variable $page in /home3/canwisac/time2study.in/inc/metatags.php on line 6
Gk question on Bedaquiline, a newly launched vaccine by Health Ministry, is......
x
Support us!

If you like this site please help and make click on any of these buttons!

Bedaquiline, a newly launched vaccine by Health Ministry, is related with the treatment of which disease?

(Click on suggested Options to select the answer | Color Red means : Wrong & Green Means: Correct)
Bedaquiline, a newly launched vaccine by Health Ministry, is related with the treatment of which disease?

Related Questions

The government on 23 April 2015 notified that it will launch a toll-free helpline for the patients suffering from which disease, whereby even a missed call would suffice to connect them with the health programme against the disease?
Under which scheme in India did the Union Health Minister of Health & Family Welfare launched various new health initiatives worth 500 crore Rupees in Assam at Guwahati?
Union government launched injectable Inactivated Polio Vaccine (IPV) in India as part of its commitment to the Global Polio Endgame Strategy'. In the first phase, this vaccine will be introduced in which States?
Who is the newly appointed secretary of Ministry of Information and Broadcasting (I & B)?

Which State government has signed the MoU with Union Ministry of Health to set up Center of Execellence in Transfusion of Medicine?

Discussion

  1. Leave a comment

Other Important General Knowledge Questions and Answer on Health

Get general knowledge question on Bedaquiline, a newly launched vaccine by Health Ministry, is related with the treatment of which disease? . It is best platform to learn more about this question as it come with number of suggest clues. User’s need to read the question very clearly and understand that before they attempt to answer it. Pls. suggest / give feedback if you have related to this question.

ENTER YOUR DETAILS!!
Please to get more information
Please enter Roll NO
By clicking on Submit button, you agree to our terms of use